Increased soluble CD 36 is linked to advanced steatosis in nonalcoholic fatty liver disease

García‐Monzón, Carmelo; Lo Iacono, Oreste; Crespo, Javier; Romero‐Gómez, Manuel; García‐Samaniego, Javier; Fernández‐Bermejo, Miguel; Domínguez‐Díez, Agustín; Rodríguez de Cía, Javier; Sáez, Alicia; Luis Porrero Carro, José; Vargas‐Castrillón, Javier; Chávez‐Jiménez, Enrique; Soto‐Fernández, Susana; Díaz, Ainhoa; Gallego‐Durán, Rocío; Madejón, Antonio; E. Miquilena-Colina, María

doi:10.1111/eci.12192

Public

Increased soluble CD 36 is linked to advanced steatosis in nonalcoholic fatty liver disease

Published in European Journal of Clinical Investigation • Oct 17, 2013

Authors:

Carmelo García‐Monzón

Oreste Lo Iacono

Javier Crespo

Abstract

BACKGROUND: Soluble CD36 (sCD36) clusters with insulin resistance, but no evidence exists on its relationship with hepatic fat content. We determined sCD36 to assess its link to steatosis in nonalcoholic fatty liver disease (NAFLD) and chronic hepatitis C (CHC) patients. MATERIALS AND METHODS: Two h...

Subject

Steatosis

Nonalcoholic fatty liver disease

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!